Nikola Arsic

Title: Innovations in Oncology by Nikola Arsic

Introduction

Nikola Arsic is a prominent inventor based in Montpellier, France. He has made significant contributions to the field of oncology, particularly in the study of cancer stem cells. With two patents to his name, Arsic's work focuses on innovative methods for understanding and treating cancer.

Latest Patents

Arsic's latest patents include "Delta133P53Beta and Delta133P53Gamma isoforms are biomarkers of cancer stem cells." This invention relates to a method for producing cancer stem cells through the overexpression of Δ133p53β isoform, Δ133p53γ isoform, or both. Additionally, it provides a method for predicting the risk that treatment with a chemotherapeutic anti-cancer agent induces cancer stem cells in a subject suffering from cancer. This prediction is based on detecting an increase in Δ133p53β isoform, Δ133p53γ isoform, or both following treatment. The patent also discusses therapeutic uses of a combination of chemotherapeutic agents and agents that reduce the expression of these isoforms, as well as screening methods for anti-cancer stem cell agents.

Career Highlights

Throughout his career, Nikola Arsic has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and Université de Montpellier. His research has significantly advanced the understanding of cancer biology and treatment strategies.

Collaborations

Arsic has collaborated with notable colleagues, including Pierre Roux and Gilles Gadea. These partnerships have contributed to the development of innovative solutions in cancer research.

Conclusion

Nikola Arsic's contributions to oncology through his patents and collaborations highlight his commitment to advancing cancer research and treatment. His work continues to pave the way for new therapeutic approaches in the fight against cancer.